Topiramate

CAS 97240-79-4 19 current records 9 historicalSmall Molecule

Who holds supplier records for Topiramate? 19 organisations hold a current record for Topiramate: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (14), Belgium (1), Taiwan (1), Poland (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Topiramate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/topiramate

Reading the evidence

  • 19 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    14 of the 18 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 14 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Topiramate expires 21 Aug 2040. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (19)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Topiramate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India14Belgium1Taiwan1Poland1China1Country not recorded for 1
Need Topiramate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Topiramate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
HETERO DRUGS LIMITED HyderabadIN
CEP 2020-130 - Rev 02
Topiramate
Feb 2026—
ZYDUS LIFESCIENCES LIMITED VadodaraIN
CEP 2021-419 - Rev 02
Topiramate
Sept 2025—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2020-140 - Rev 04
Topiramate
Mar 2025—
MSN ORGANICS PRIVATE LIMITED Bibinagar VillageIN
R0-CEP 2020-201 - Rev 01
Topiramate
Mar 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (9)

Organisations whose Type II DMFs for Topiramate are no longer active. These show a past filing, not current supply.

Show all 9 historical records
  • India · Inactive DMF 24833, 27439 · filed Sept 2013
  • DISHMAN PHARMACEUTICALS AND CHEMICALS LTD
    Inactive DMF 26919, 22745 · filed Feb 2013
  • SIGNA SA DE CV
    Inactive DMF 21657 · filed May 2008
  • India · Inactive DMF 21068 · filed Nov 2007
  • India · Inactive DMF 19325 · filed Mar 2006
  • CF PHARMA LTD
    Inactive DMF 18269 · filed Apr 2005
  • Hungary · Inactive DMF 16405 · filed Jan 2003
  • FERRO PFANSTIEHL LABORATORIES INC
    Inactive DMF 15658 · filed Oct 2001
  • Switzerland · Inactive DMF 10978 · filed Jul 1994

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (137 listed products contain Topiramate). The latest listed patent expires 21 Aug 2040. The latest listed exclusivity ended 1 Feb 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Topiramate is a medication used primarily to treat epilepsy and prevent migraines. It is known for its broad-spectrum anticonvulsant properties and is generally well-tolerated in diverse patient populations.

Chemical identity

IUPAC name
[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate
Canonical SMILES
CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C
InChIKey
KJADKKWYZYXHBB-XBWDGYHZSA-N
Synonyms
Topamax API, (-)-topiramate, epitoma, epitomax, eprontia, mcn-4853, qsymia component topiramate, qudexy, rwj-17021, rwj-17021-000, sincronil, topamac

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Mechanism of action
Cytochrome P450 2C19 Inhibitors; Cytochrome P450 3A4 Inducers
Physiologic effect
Decreased Central Nervous System Disorganized Electrical Activity

Therapeutic areas

AntiepilepticMigraine Prevention

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Topiramate?

19 organisations hold an active US FDA Type II Drug Master File or a CEP for Topiramate: UNIMARK REMEDIES LTD (India), APITORIA PHARMA PRIVATE LTD (India), Hetero Drugs Limited (India), MSN Organics Private Limited (India), Zydus Lifesciences Limited (India), ALIVUS LIFE SCIENCES LTD (India), Cipla Limited (India) and Dr. Reddy's Laboratories Ltd. (India), and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Topiramate Drug Master Files are active?

UNIMARK REMEDIES LTD (DMF 23349, 20932), APITORIA PHARMA PRIVATE LTD (DMF 19247), Hetero Drugs Limited (DMF 18346), MSN Organics Private Limited (DMF 25713), Zydus Lifesciences Limited (DMF 18700), ALIVUS LIFE SCIENCES LTD (DMF 17729), Cipla Limited (DMF 15693) and Dr. Reddy's Laboratories Ltd. (DMF 16533) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Topiramate records mean?

9 organisations have only inactive Type II DMFs for Topiramate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Topiramate have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Topiramate on the EDQM register, including HETERO DRUGS LIMITED Hyderabad (IN), ZYDUS LIFESCIENCES LIMITED Vadodara (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and MSN ORGANICS PRIVATE LIMITED Bibinagar Village (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Topiramate?

Yes. The latest patent listed for an approved US product containing Topiramate expires 21 Aug 2040, across 137 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Topiramate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Topiramate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.